Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Thomas Little is active.

Publication


Featured researches published by Thomas Little.


Bioorganic & Medicinal Chemistry Letters | 1998

Highly efficient and versatile synthesis of libraries of constrained β-strand mimetics

Cyprian O. Ogbu; Maher Qabar; P. Douglas Boatman; Jan Urban; Joseph Patrick Meara; Mark D. Ferguson; John Tulinsky; Chris Lum; Suresh Babu; Mark A. T. Blaskovich; Hiroshi Nakanishi; Fuqiang Ruan; Bolong Cao; Ryan Minarik; Thomas Little; Sherry Nelson; Minh T. Nguyen; Anna Gall; Michael Kann

The general approach of using a bicyclic template to produce inhibitors of the protease superfamily of enzymes has been investigated. The Diels-Alder cycloaddition reaction on solid support has been found to be highly efficient for the synthesis of libraries of compounds that mimic the β-strand secondary structure of proteins. Several potent and selective inhibitors of proteases have been discovered.


Synthetic Communications | 2002

EFFICIENT SYNTHESIS OF NOVEL 4-SUBSTITUTED URAZOLES

Thomas Little; Joseph Patrick Meara; Fuqiang Ruan; Minh T. Nguyen; Maher Qabar

ABSTRACT The efficient synthesis of several new and novel 4-substituted triazolidindiones (urazoles) starting from isocyanates, amines, anilines and carboxylic acids is reported.


Bioorganic & Medicinal Chemistry Letters | 2003

Sulphonamide-based small molecule VLA-4 antagonists

Marcin Stasiak; Christopher Mehlin; Erica Boni; Tomas Vaisar; Thomas Little; Hwa Ok Kim; Maher Qabar

The discovery of a sulphonamide by-product with VLA-4 antagonistic activity led to a series of potent, small molecule VLA-4 antagonists. Synthesis, SAR and in vivo evaluation of the selected compound will be presented.


Archive | 2011

PDE10 inhibitors and related compositions and methods

Neil S. Cutshall; Jennifer Lynn Gage; Thomas Neil Wheeler; Thomas Little


Archive | 2008

Amine derivative compounds for treating ophthalmic diseases and disorders

Ian L. Scott; Vladimir Kuksa; Mark W. Orme; Feng Hong; Thomas Little; Ryo Kubota


Archive | 2005

Protein tyrosine phosphatase inhibitors and methods of use thereof

Mark A. T. Blaskovich; Ted Baughman; Thomas Little; William Patt; Maher Qabar; Lauri Schultz; Feng Hong; Gangadhar Nagula; Jennifer Gage; James Jeffrey Howbert


Archive | 2011

Alkoxy compounds for disease treatment

Ian L. Scott; Vladimir Kuksa; Mark W. Orme; Thomas Little; Anna Gall; Feng Hong


Archive | 2008

Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders

Ian L. Scott; Vladimir Kuksa; Mark W. Orme; Thomas Little; Anna Gall; Jennifer Gage; Feng Hong


Archive | 2008

Styrenyl derivative compounds for treating ophthalmic diseases and disorders

Ian L. Scott; Vladimir Aleksandrovich Kuska; Anna Gall; Mark W. Orme; Jennifer Gage; Thomas Little; Qin Jiang; Lana Michele Rossiter; Kevin F Mcgee; Ryo Kubota


Archive | 2015

PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF A PDE10 INHIBITOR

Neil S. Cutshall; Jennifer Lynn Gage; Thomas Little; Wayne Douglas Luke; Elisabeth C.A. Brot; Marco Jonas; Michael James Mcdermott; Karl Reineke

Collaboration


Dive into the Thomas Little's collaboration.

Top Co-Authors

Avatar

Vladimir Kuksa

University of Washington

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Maher Qabar

Wayne State University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Joseph Patrick Meara

University of Wisconsin-Madison

View shared research outputs
Researchain Logo
Decentralizing Knowledge